27.7607.96% ( -2.400 )
Delay Closed: Nov 20, 16:08:18Valuation
Current ValuationThe current P/E ratio is -12.70, within the reasonable range, cheaper than 29.04% of the time in the past 5 years, and the industry ranks 12/15, the industry Median 11.44.
-12.7xP/E
HK$27.76Stock price
HK$-2.19Earnings per share
-12.7xP/E
Stock priceHK$27.76Earnings per shareHK$-2.19
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -18.39x
- Typical range
- -29.19x–0.94x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.44x
011223344
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.44x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
01548HKGENSCRIPT BIO | -12.70x | 102.63% | HK$63.40B |
03347HKTIGERMED | -57.70x | -- | HK$27.19B |
02228HKXTALPI | -84.91x | 167.69% | HK$20.62B |
03696HKINSILICO | -7.69x | 100.21% | HK$17.94B |
02576HKTAIMEI TECH | -33.83x | -- | HK$2.54B |
08225HKC HEALTH GP | -4.58x | -- | HK$74.65M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
